-+ 0.00%
-+ 0.00%
-+ 0.00%

SENSEI BIOTHERAPEUTICS DOSES FIRST PATIENT IN PHASE 1B/2 TRIAL OF PIKTOR IN HR+/HER2- ADVANCED BREAST CANCER

Reuters·05/05/2026 11:30:01

Please log in to view news